Related Experiment Video
Updated: May 3, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial
Xiao-Dong Zhang1, Jun Gu1, Wei-Feng Jiang1
1Department of Cardiology, Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, 241 West Huaihai Road, Shanghai 200030, China.
Insights
Catheter ablation (CA) is superior to antiarrhythmic drugs (AAD) for treating recurrent atrial tachycardia (AT) after atrial fibrillation (AF) ablation, improving quality of life. However, CA carries a higher risk of immediate complications.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Interventions
Background:
- Catheter ablation (CA) is a primary treatment for atrial fibrillation (AF).
- Optimal management for recurrent atrial tachycardia (AT) post-AF ablation remains uncertain.
- This study addresses the CA versus antiarrhythmic drugs (AAD) debate for recurrent AT.
Purpose of the Study:
- To compare the efficacy and safety of CA versus AAD for recurrent AT following persistent AF ablation.
- To evaluate long-term outcomes, including freedom from atrial tachyarrhythmia (ATa), complications, and quality of life (QoL).
Main Methods:
- A parallel randomized controlled trial involving 201 patients with recurrent AT post-AF ablation.
- Patients were randomized to either CA (n=101) or AAD (n=100).
- Primary endpoint: freedom from ATa at 24 months. Secondary endpoints: complications, morbidity, QoL.
Main Results:
- CA demonstrated a significantly higher rate of freedom from ATa (56.4% vs. 34.0%; P=0.001) compared to AAD.
- CA was associated with more periprocedural complications (7.9% vs. 0%; P=0.012).
- AAD group experienced more long-term adverse events (24.0% vs. 10.9%; P=0.014), and CA improved QoL.
Conclusions:
- Catheter ablation is superior to AAD for maintaining sinus rhythm and improving QoL in patients with recurrent AT post-AF ablation.
- CA offers better long-term safety and QoL compared to AAD.
- The increased risk of periprocedural complications with CA warrants consideration.
Aim:
Although catheter ablation (CA) has replaced antiarrhythmic drugs (AAD) as first-line treatment in selected patients with atrial fibrillation (AF), optimal treatment of recurrent atrial tachycardia (AT) after AF ablation remains unclear. This parallel randomized controlled study compared CA vs. AAD for recurrent AT after persistent AF ablation.
Methods And Results:
Two-hundred and one patients (aged 59.1 ± 10.9 years, 68.7% male) with recurrent AT after persistent AF ablation were enrolled and randomized to either CA (n = 101) or AAD (n = 100) treatment. Primary endpoint was freedom from recurrent atrial tachyarrhythmia (ATa, including AT and AF) at 24-month follow-up. Composite secondary endpoints comprised procedural complications, long-term morbidity and improvement in quality of life (QoL). On an intention-to-treat basis, the CA group had a higher rate of freedom from recurrent ATa (56.4 vs. 34.0%; P = 0.001). Adjusted Cox regression analysis showed a significant treatment effect with a hazard ratio of 0.538 (95% CI: 0.355-0.816) in favour of CA. There was a higher proportion of periprocedural complications in the CA group (7.9 vs. 0; P = 0.012), and of long-term adverse events in the AAD group (10.9 vs. 24.0%; P = 0.014). Quality of life was significantly higher for CA.
Conclusions:
This study demonstrates superiority of CA over AAD for recurrent AT after persistent AF ablation with regard to SR maintenance, long-term safety and QoL improvement. However, CA use might be limited by a higher risk for periprocedural complications.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...

